Published in J Immunol on November 01, 1988
Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli. Infect Immun (1993) 1.04
Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis. Med Microbiol Immunol (2005) 0.82
Pyelonephritis in slaughter pigs and sows: morphological characterization and aspects of pathogenesis and aetiology. Acta Vet Scand (2010) 0.75
Estimation of the relationship between the polymorphisms of selected genes: ACE, AGTR1, TGFβ1 and GNB3 with the occurrence of primary vesicoureteral reflux. Int Urol Nephrol (2016) 0.75
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol (1986) 10.92
Infection in organ-transplant recipients. N Engl J Med (1998) 6.49
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99
Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med (1966) 5.26
Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood (1989) 5.08
Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest (1998) 3.85
Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol (1981) 3.71
Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med (1989) 3.70
Distribution of T cell subsets in human lymph nodes. J Exp Med (1981) 3.64
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med (1980) 3.41
Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33
Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol (1984) 3.26
Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity (1998) 2.92
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol (1983) 2.90
Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J Immunol (1984) 2.84
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci U S A (1996) 2.79
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
The distribution of large dividing lymph node cells in syngeneic recipient rats after intravenous injection. J Exp Med (1969) 2.76
An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med (1966) 2.70
BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol (1985) 2.66
Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med (1968) 2.60
Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58
Stages of B cell differentiation in human lymphoid tissue. J Exp Med (1981) 2.49
The distribution of antigenic and nonantigenic compounds within draining lymph nodes. Lab Invest (1966) 2.49
Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science (1989) 2.48
Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med (1975) 2.46
Immunohistologic and immunoelectron microscopic characterization of the mucosal lymphocytes of human small intestine by the use of monoclonal antibodies. J Immunol (1983) 2.44
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst (1995) 2.44
Infective endocarditis--1973. Prog Cardiovasc Dis (1974) 2.42
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol (1998) 2.42
Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A (1988) 2.36
Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. N Engl J Med (1978) 2.33
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med (1970) 2.29
Surgical aspects of continuous ambulatory peritoneal dialysis--3 years experience. Br J Surg (1984) 2.28
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med (1997) 2.21
Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. Am J Med (1974) 2.21
Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol (2001) 2.20
Permanent neurological sequelae despite haemodialysis for lithium intoxication. Br Med J (1972) 2.14
Studies of PPLO infection. I. The production of cerebral polyarteritis by Mycoplasma gallisepticum in turkeys; the neurotoxic property of the Mycoplasma. J Exp Med (1966) 2.13
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Severe colitis in mice with aberrant thymic selection. Immunity (1995) 2.11
Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest (1999) 2.09
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol (1986) 2.06
The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J Immunol (1984) 2.02
Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med (1978) 1.98
Effect of age on calcium absorption. Lancet (1970) 1.98
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens (1998) 1.96
CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A (1994) 1.96
Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell (1982) 1.95
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med (1990) 1.92
Passive transfer of Heymann nephritis with serum. Kidney Int (1973) 1.91
Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med (1996) 1.91
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer (2011) 1.86
Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol (1993) 1.84
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol Cell Biol (1990) 1.81
A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrob Agents Chemother (1989) 1.78
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med (1989) 1.76
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest (1981) 1.73
Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J Histochem Cytochem (1994) 1.72
In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood (1982) 1.71
Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest (1985) 1.71
Reversible renal failure during treatment with captopril. Br Med J (1979) 1.70
Polyethylene glycol 4000 as a continuously administered non-absorbable faecal marker for metabolic balance studies in human subjects. Gut (1971) 1.69
Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides. Br Med J (Clin Res Ed) (1986) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Br J Cancer (1986) 1.66
Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med (1991) 1.65
Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology (1998) 1.65
Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. Q J Med (1990) 1.61
Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. J Immunol (1984) 1.60
Studies on the specificity of the cellular infiltrate of delayed hypersensitivity reactions. J Immunol (1967) 1.60
Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med (1996) 1.59
Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. J Am Acad Dermatol (1991) 1.59
Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood (1981) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Withdrawal of renal replacement therapy in Newcastle upon Tyne: 1964-1993. Nephrol Dial Transplant (1996) 1.56
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother (1993) 1.55
Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. J Pediatr (1991) 1.55
The crush fracture syndrome in postmenopausal women. Clin Endocrinol Metab (1973) 1.53
Nursing implications of the department of health guidelines on admission to and discharge from intensive care and high dependency units. A joint statement from the British Association of Critical Care Nurses and The Royal College of Nursing Critical Care Forum. Intensive Crit Care Nurs (1996) 1.53
Immunopathologic study of an autoimmune tubular and interstitial renal disease in brown Norway rats. Lab Invest (1973) 1.52
Oligoclonality of human intestinal intraepithelial T cells. J Exp Med (1992) 1.51